Biocartis
Biocartis, Eli Lilly Partner for Spanish NSCLC Biomarker Study
The study aims to establish how Biocartis' Idylla molecular testing platform can eventually be used to improve community-based diagnostic workflows in the US.
Top Five Articles on 360Dx Last Week: Biocartis Reorganizing; CDC's New Training Program; and More
Last week, readers were most interested in a story about layoffs at Biocartis as part of a plan to save €18 million in annual operating expenses.
Biocartis Laying Off 140 Employees as Part of Reorganization Plan
The layoffs, which constitute 25 percent of the company's workforce, are part of a restructuring effort intended to reduce annual operating expenses by €18 million.
In Brief This Week: Quest Diagnostics, Abbott, Biocept, Biocartis, Angle, Virax Biolabs
News items for the week of April 17, 2023.
Biocartis, Apis Assay Technologies to Develop Breast Cancer Subtyping Test
Apis will lead the development of the test on Biocartis' Idylla platform, while Biocartis will lead the commercialization of the assay.
Oct 10, 2022
Ophiomics Liver Cancer Assay Gets CE-IVD Mark
Sep 1, 2022
Biocartis Posts 21 Percent Jump in H1 Revenues
Jun 22, 2022
Biocartis, AstraZeneca Ink Companion Diagnostic Pact
Jun 20, 2022
Biocartis Nabs CE Mark for Lung Cancer Test
Feb 24, 2022
Biocartis Reports 12 Percent Rise in 2021 Revenues
Sep 2, 2021